Literature DB >> 23117501

Transmission of risk-group specific HIV-1 strains among Dutch drug users for more than 20 years and their replacement by nonspecific strains after switching to low-harm drug practices.

Vladimir V Lukashov1, Suzanne Jurriaans, Margreet Bakker, Ben Berkhout.   

Abstract

OBJECTIVES: To characterize HIV-1 epidemiological networks of men having sex with men (MSM) and drug users (DUs) in the Netherlands for >30 years. DESIGN AND METHODS: Previously, we demonstrated different origin of the HIV-1 epidemics in Dutch MSM and DUs. To achieve the study objectives, risk group-specific genetic markers in the pol gene were examined in 315 participants of the Amsterdam Cohort Studies on HIV/AIDS who were registered as HIV-1 infected in 1981-2011.
RESULTS: Phylogenetic analysis demonstrated circulation of distinct virus strains in the 2 networks, with 98% of viruses of MSM clustering together and apart from strains of 73% DUs. Nine genetic markers that significantly distinguished virus strains specific for DUs were identified, of which 3 were ≥90% conserved. Over the total observation period, only 6% of viruses (4 of MSM and 14 of DUs) clustered with those of the other risk group. Among these sequences, the 3 most conserved genetic markers of that other risk group were 87% conserved.All 4 cases of DU-specific viruses among MSM occurred in 1980s-early 1990s. Viruses nonspecific for DUs were causing new infections among DUs at the rate of 20% till 2002 and replaced DU-specific strains among new infections thereafter, coinciding with switching of DUs to low-harm drug practices.
CONCLUSIONS: Dutch MSM and DUs have remained separate epidemiological networks for decades, despite their geographical and behavioral overlap. Switching to low-harm drug practices among DUs resulted in new infections caused by HIV-1 strains originating from other risk groups.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23117501     DOI: 10.1097/QAI.0b013e318279734d

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  6 in total

1.  HIV-1 tolerates changes in A-count in a small segment of the pol gene.

Authors:  Bep Klaver; Yme van der Velden; Formijn van Hemert; Antoinette C van der Kuyl; Ben Berkhout
Journal:  Retrovirology       Date:  2017-09-05       Impact factor: 4.602

Review 2.  Defining HIV-1 transmission clusters based on sequence data.

Authors:  Amin S Hassan; Oliver G Pybus; Eduard J Sanders; Jan Albert; Joakim Esbjörnsson
Journal:  AIDS       Date:  2017-06-01       Impact factor: 4.177

3.  HIV-1 molecular transmission clusters in nine European countries and Canada: association with demographic and clinical factors.

Authors:  Dimitrios Paraskevis; Apostolos Beloukas; Kostantinos Stasinos; Nikos Pantazis; Carmen de Mendoza; Norbert Bannert; Laurence Meyer; Robert Zangerle; John Gill; Maria Prins; Antonella d'Arminio Montforte; Anne-Marte Bakken Kran; Kholoud Porter; Giota Touloumi
Journal:  BMC Med       Date:  2019-01-08       Impact factor: 8.775

4.  Drug users in Amsterdam: are they still at risk for HIV?

Authors:  Nienke van der Knaap; Bart P X Grady; Maarten F Schim van der Loeff; Titia Heijman; Arjen Speksnijder; Ronald Geskus; Maria Prins
Journal:  PLoS One       Date:  2013-03-18       Impact factor: 3.240

Review 5.  Translational HIV-1 research: from routine diagnostics to new virology insights in Amsterdam, the Netherlands during 1983-2013.

Authors:  Antoinette C van der Kuyl; Margreet Bakker; Suzanne Jurriaans; Nicole K T Back; Alexander O Pasternak; Marion Cornelissen; Ben Berkhout
Journal:  Retrovirology       Date:  2013-08-28       Impact factor: 4.602

6.  Toll-like receptor 7-adapter complex modulates interferon-α production in HIV-stimulated plasmacytoid dendritic cells.

Authors:  Andy A Patamawenu; Nathaniel E Wright; Tulley Shofner; Sean Evans; Maura M Manion; Nicole Doria-Rose; Stephen A Migueles; Daniel Mendoza; Bennett Peterson; Christopher Wilhelm; Julia Rood; Amy Berkley; Nancy A Cogliano; C Jason Liang; Kiki Tesselaar; Frank Miedema; Julian Bess; Jeffrey Lifson; Mark Connors
Journal:  PLoS One       Date:  2019-12-12       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.